Hexachlorocyclotriphosphazene → Trichlorotriphenoxycyclotriphosphazene

HRID 980000

반응식

HRID 980000 반응식
[Cl:1][P:2]1(Cl)[N:7]=[P:6](Cl)([Cl:8])[N:5]=[P:4]([Cl:11])(Cl)[N:3]=1.[O-:13][C:14]1[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1.[Na+]>>[Cl:1][P:2]1([O:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[N:7]=[P:6]([Cl:8])([O:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[N:5]=[P:4]([Cl:11])([O:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[N:3]=1

참가 물질

3

실험 절차

Examples 8 to 12 below illustrate embodiments of the invention in which hexachlorocyclotriphosphazene (compound 1) is reacted first with sodium phenoxide to produce an intermediate (trischlorotrisphenoxycyclotriphosphazene), 19 which is then reacted without separation with sodium 4-nitrophenoxide to afford tris(4-nitrophenoxy)tris(phenoxy)cyclotriphosphazene 20. The nitro groups of 20 are reduced to afford the corresponding tris amino compound 21 which is then used according to Scheme I or Scheme II shown in FIG. 2 and FIG. 3, respectively.

출처 및 근거

ORD 기록
ord-26873eb24d11451683ca63ba9e279889
출처 데이터셋
uspto-grants-1987_01
특허 번호
US04634759

연결된 노트

불러오는 중…